632 related articles for article (PubMed ID: 20629054)
21. Metabonomics: a useful tool for the future surgeon.
Goldsmith P; Fenton H; Morris-Stiff G; Ahmad N; Fisher J; Prasad KR
J Surg Res; 2010 May; 160(1):122-32. PubMed ID: 19592031
[TBL] [Abstract][Full Text] [Related]
22. Recent and potential developments in the analysis of urine: a review.
Ryan D; Robards K; Prenzler PD; Kendall M
Anal Chim Acta; 2011 Jan; 684(1-2):8-20. PubMed ID: 21167980
[TBL] [Abstract][Full Text] [Related]
23. The role of metabolomics in neurological disease.
Hassan-Smith G; Wallace GR; Douglas MR; Sinclair AJ
J Neuroimmunol; 2012 Jul; 248(1-2):48-52. PubMed ID: 22341863
[TBL] [Abstract][Full Text] [Related]
24. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine.
Antonucci R; Atzori L; Barberini L; Fanos V
Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):145-8. PubMed ID: 21089734
[TBL] [Abstract][Full Text] [Related]
25. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.
Serkova NJ; Niemann CU
Expert Rev Mol Diagn; 2006 Sep; 6(5):717-31. PubMed ID: 17009906
[TBL] [Abstract][Full Text] [Related]
26. Lipidomics in the study of lipid metabolism: Current perspectives in the omic sciences.
Rolim AE; Henrique-Araújo R; Ferraz EG; de Araújo Alves Dultra FK; Fernandez LG
Gene; 2015 Jan; 554(2):131-9. PubMed ID: 25445283
[TBL] [Abstract][Full Text] [Related]
27. Metabolome analysis by capillary electrophoresis-mass spectrometry.
Monton MR; Soga T
J Chromatogr A; 2007 Oct; 1168(1-2):237-46; discussion 236. PubMed ID: 17376458
[TBL] [Abstract][Full Text] [Related]
28. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
Thomas A; Lenglet S; Chaurand P; Deglon J; Mangin P; Mach F; Steffens S; Wolfender JL; Staub C
Thromb Haemost; 2011 Jul; 106(1):20-33. PubMed ID: 21614412
[TBL] [Abstract][Full Text] [Related]
29. Chemometrics in metabolomics--a review in human disease diagnosis.
Madsen R; Lundstedt T; Trygg J
Anal Chim Acta; 2010 Feb; 659(1-2):23-33. PubMed ID: 20103103
[TBL] [Abstract][Full Text] [Related]
30. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes.
Connor SC; Hansen MK; Corner A; Smith RF; Ryan TE
Mol Biosyst; 2010 May; 6(5):909-21. PubMed ID: 20567778
[TBL] [Abstract][Full Text] [Related]
31. Plasma phospholipid metabolic profiling and biomarkers of rats following radiation exposure based on liquid chromatography-mass spectrometry technique.
Wang C; Yang J; Nie J
Biomed Chromatogr; 2009 Oct; 23(10):1079-85. PubMed ID: 19382245
[TBL] [Abstract][Full Text] [Related]
32. Mass spectrometry-based metabolomics of yeast.
Crutchfield CA; Lu W; Melamud E; Rabinowitz JD
Methods Enzymol; 2010; 470():393-426. PubMed ID: 20946819
[TBL] [Abstract][Full Text] [Related]
33. Lipidomics era: accomplishments and challenges.
Bou Khalil M; Hou W; Zhou H; Elisma F; Swayne LA; Blanchard AP; Yao Z; Bennett SA; Figeys D
Mass Spectrom Rev; 2010; 29(6):877-929. PubMed ID: 20931646
[TBL] [Abstract][Full Text] [Related]
34. Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases.
Mishur RJ; Rea SL
Mass Spectrom Rev; 2012; 31(1):70-95. PubMed ID: 21538458
[TBL] [Abstract][Full Text] [Related]
35. Drug bioanalysis and biomarker discovery at the Commissariat à l'énergie atomique et aux énergies alternatives.
Ezan E; Becher F; Benech H; Fenaille F; Junot C; Mabondzo A; Pruvost A
Bioanalysis; 2010 Apr; 2(4):713-7. PubMed ID: 21083268
[No Abstract] [Full Text] [Related]
36. Lipid-based biomarkers for cancer.
Fernandis AZ; Wenk MR
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2830-5. PubMed ID: 19570730
[TBL] [Abstract][Full Text] [Related]
37. Protein biomarker discovery and validation: the long and uncertain path to clinical utility.
Rifai N; Gillette MA; Carr SA
Nat Biotechnol; 2006 Aug; 24(8):971-83. PubMed ID: 16900146
[TBL] [Abstract][Full Text] [Related]
38. [Research progress and application of shotgun lipidomics].
Bai XJ; Ding W
Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):323-8. PubMed ID: 21416920
[TBL] [Abstract][Full Text] [Related]
39. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.
Zhao YY; Lin RC
Chem Biol Interact; 2014 May; 215():7-16. PubMed ID: 24631021
[TBL] [Abstract][Full Text] [Related]
40. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
